Status
Global HQ
Uppsala, Sweden
Countries of investment
Investment stages
Industries
About
Novavax is a pioneering biotech company creating transformative vaccines using recombinant nanoparticle technology to combat infectious diseases globally, including rapid responses to emerging threats like COVID-19.
Novavax is a pioneering biotech company creating transformative vaccines using recombinant nanoparticle technology to combat infectious diseases globally, including rapid responses to emerging threats like COVID-19.
Investment Thesis
Manager's Experience
With a strong emphasis on healthcare and biotech investments, the fund manager has executed over 30 deals across North America and Europe. His strategic approach combines a data-driven methodology with a thematic focus on innovative therapies and vaccine development. Notable exits include several successful IPOs, demonstrating a robust track record of value creation. His operator-first style fosters collaboration with portfolio companies to drive growth and enhance operational efficiency.